Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2024 is 3.81% vs 8.05% in Dec 2023
Consolidate Net Profit
YoY Growth in quarter ended Dec 2024 is -23.29% vs 48.01% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2024 is -2.31% vs 7.08% in Dec 2023
Interest
YoY Growth in quarter ended Dec 2024 is 46.74% vs 3.90% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023
Compare Quarterly Results Of Alembic Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2024 is 2.72% vs 5.52% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 3.81% vs 8.05% in Dec 2023
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2024 is -9.77% vs 13.88% in Sep 2024
YoY Growth in quarter ended Dec 2024 is -23.29% vs 48.01% in Dec 2023
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2024 is 8.76% vs 1.03% in Sep 2024
YoY Growth in quarter ended Dec 2024 is -2.31% vs 7.08% in Dec 2023
Quarterly - Interest
QoQ Growth in quarter ended Dec 2024 is 18.34% vs 42.72% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 46.74% vs 3.90% in Dec 2023
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024
YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023